Star Lake BioscienceZhaoqing Guangdong Future Growth
Future criteria checks 1/6
Star Lake BioscienceZhaoqing Guangdong is forecast to grow earnings and revenue by 18.1% and 3.1% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 14.4% in 3 years.
Key information
18.1%
Earnings growth rate
18.1%
EPS growth rate
| Food earnings growth | 22.3% |
| Revenue growth rate | 3.1% |
| Future return on equity | 14.4% |
| Analyst coverage | Low |
| Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem
Nov 04
Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly
Oct 27Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings
Sep 25Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth
Jul 26Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)
May 28There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise
Apr 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 18,479 | 1,356 | N/A | 3,210 | 2 |
| 12/31/2025 | 17,823 | 1,197 | N/A | 1,380 | 2 |
| 12/31/2024 | 17,062 | 1,026 | N/A | 2,416 | 2 |
| 9/30/2024 | 17,435 | 866 | 1,647 | 2,173 | N/A |
| 6/30/2024 | 17,594 | 954 | 1,593 | 2,009 | N/A |
| 3/31/2024 | 17,410 | 809 | 2,150 | 2,512 | N/A |
| 12/31/2023 | 17,374 | 678 | 1,650 | 2,026 | N/A |
| 9/30/2023 | 17,343 | 598 | 1,231 | 1,503 | N/A |
| 6/30/2023 | 16,932 | 429 | 1,345 | 1,680 | N/A |
| 3/31/2023 | 17,479 | 546 | 445 | 845 | N/A |
| 12/31/2022 | 17,486 | 608 | 1,210 | 1,663 | N/A |
| 9/30/2022 | 16,084 | 595 | 1,493 | 2,009 | N/A |
| 6/30/2022 | 12,294 | 497 | 181 | 630 | N/A |
| 3/31/2022 | 7,938 | 301 | -78 | 312 | N/A |
| 12/31/2021 | 4,071 | 152 | -182 | 168 | N/A |
| 9/30/2021 | 1,170 | 96 | -38 | 171 | N/A |
| 6/30/2021 | 1,129 | 130 | -123 | 142 | N/A |
| 3/31/2021 | 1,134 | 151 | -114 | 210 | N/A |
| 12/31/2020 | 1,116 | 149 | -40 | 250 | N/A |
| 9/30/2020 | 1,011 | 137 | -150 | 159 | N/A |
| 6/30/2020 | 1,081 | 156 | -104 | 171 | N/A |
| 3/31/2020 | 1,038 | 145 | 2 | 183 | N/A |
| 12/31/2019 | 1,050 | 150 | 56 | 213 | N/A |
| 9/30/2019 | 1,061 | 132 | 136 | 226 | N/A |
| 6/30/2019 | 969 | 103 | 150 | 181 | N/A |
| 3/31/2019 | 926 | 71 | 75 | 104 | N/A |
| 12/31/2018 | 859 | 42 | 17 | 51 | N/A |
| 9/30/2018 | 849 | -82 | -23 | 16 | N/A |
| 6/30/2018 | 852 | -101 | N/A | 28 | N/A |
| 3/31/2018 | 805 | -124 | N/A | 72 | N/A |
| 12/31/2017 | 687 | -158 | N/A | 50 | N/A |
| 9/30/2017 | 668 | -35 | N/A | 52 | N/A |
| 6/30/2017 | 634 | 1 | N/A | 34 | N/A |
| 3/31/2017 | 638 | 22 | N/A | 28 | N/A |
| 12/31/2016 | 680 | 24 | N/A | 41 | N/A |
| 9/30/2016 | 618 | -232 | N/A | 11 | N/A |
| 6/30/2016 | 621 | -333 | N/A | 2 | N/A |
| 3/31/2016 | 656 | -397 | N/A | -11 | N/A |
| 12/31/2015 | 730 | -422 | N/A | 3 | N/A |
| 9/30/2015 | 882 | -312 | N/A | 60 | N/A |
| 6/30/2015 | 923 | -319 | N/A | 89 | N/A |
| 3/31/2015 | 912 | -353 | N/A | 53 | N/A |
| 12/31/2014 | 871 | -361 | N/A | -20 | N/A |
| 9/30/2014 | 819 | -163 | N/A | -57 | N/A |
| 6/30/2014 | 817 | -77 | N/A | -58 | N/A |
| 3/31/2014 | 856 | 19 | N/A | -81 | N/A |
| 12/31/2013 | 903 | 20 | N/A | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600866's forecast earnings growth (18.1% per year) is above the savings rate (2.8%).
Earnings vs Market: 600866's earnings (18.1% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 600866's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600866's revenue (3.1% per year) is forecast to grow slower than the CN market (13.9% per year).
High Growth Revenue: 600866's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600866's Return on Equity is forecast to be low in 3 years time (14.4%).